Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:48 PM
2.80% (1D)
| Bid | 1.1 |
| Market Cap | 127.44M |
| Revenue (ttm) | 13.34M |
| Net Income (ttm) | -175.88M |
| EPS (ttm) | -1.46 |
| PE Ratio (ttm) | -0.76 |
| Forward PE | -0.71 |
| Analyst | Hold |
| Ask | 1.11 |
| Volume | 1,481,615 |
| Avg. Volume (20D) | 1,724,217 |
| Open | 1.09 |
| Previous Close | 1.07 |
| Day's Range | 1.08 - 1.16 |
| 52-Week Range | 0.66 - 4.20 |
| Beta | 2.25 |
About FATE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FATE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FATE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Fate Therapeutics has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Fate Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+20.69%
Fate Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+21.17%
Fate Therapeutics shares are trading higher after the FDA recently granted Regenerative Medicine Advanced Therapy designation to FT819.
